Altrock et al. evaluated the feasibility of this approach [8, 9] in MDS and used a standardized approach to compare the 3D ossicle-based method to intrafemoral (IF) co-injection of MSCs and CD34+ HSPCs [41]. Here, CD34 is linked to myelodysplastic syndrome.